We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current KZR market cap is 61.51M. The company's latest EPS is USD -1.3993 and P/E is -0.59.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 7M |
| Operating Income | -18.93M | -20.03M | -24.52M | -26.78M | -25.53M |
| Net Income | -17.85M | -18.18M | -22.2M | -24.31M | -23.1M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 7M |
| Operating Income | -37.34M | -42.95M | -54.66M | -71.16M | -111.42M |
| Net Income | -35.09M | -41.74M | -54.63M | -68.24M | -101.87M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 304.77M | 299.57M | 284.18M | 263.38M | 249.33M |
| Total Liabilities | 21.58M | 29.7M | 31.69M | 31.1M | 33.33M |
| Total Equity | 283.19M | 269.87M | 252.49M | 232.28M | 215.99M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 89.51M | 151.84M | 217.93M | 299.57M | 221.24M |
| Total Liabilities | 11.47M | 10.86M | 21.06M | 29.7M | 33.67M |
| Total Equity | 78.05M | 140.98M | 196.88M | 269.87M | 187.57M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -42.96M | -58.85M | -20.86M | -42.46M | -62.67M |
| Investing | -82.73M | -91.39M | 16.39M | 29.59M | 48.17M |
| Financing | 127.36M | 127.86M | 154k | 536k | 579k |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -29.88M | -36.95M | -42.44M | -58.85M | -81.65M |
| Investing | 20.42M | -56.5M | -28.44M | -91.39M | 76.05M |
| Financing | 272k | 99.64M | 112.59M | 127.86M | 638k |
| Market Cap | 61.51M |
| Price to Earnings Ratio | -0.59 |
| Price to Sales Ratio | 8.52 |
| Price to Cash Ratio | 1.68 |
| Price to Book Ratio | 0.32 |
| Dividend Yield | - |
| Shares Outstanding | 72.8M |
| Average Volume (1 week) | 546.02k |
| Average Volume (1 Month) | 652.79k |
| 52 Week Change | -64.05% |
| 52 Week High | 3.13 |
| 52 Week Low | 0.6746 |
| Spread (Intraday) | 0.05 (5.82%) |
| Company Name | Kezar Life Sciences Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://kezarlifesciences.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
